GLYCOSAN Trademark

Trademark Overview

On Thursday, July 8, 2021, a trademark application was filed for GLYCOSAN with the United States Patent and Trademark Office. The USPTO has given the GLYCOSAN trademark a serial number of 90818292. The federal status of this trademark filing is SUSPENSION INQUIRY - MAILED as of Monday, February 3, 2025. This trademark is owned by Oligo Médic Inc.. The GLYCOSAN trademark is filed in the Chemical Products category with the following description:

Chitosan-based polymers for use in the manufacture of pharmaceuticals
glycosan

General Information

Serial Number90818292
Word MarkGLYCOSAN
Filing DateThursday, July 8, 2021
Status651 - SUSPENSION INQUIRY - MAILED
Status DateMonday, February 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesChitosan-based polymers for use in the manufacture of pharmaceuticals

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, September 16, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOligo Médic Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLaval, QC H7V5B7
CA

Trademark Events

Event DateEvent Description
Monday, July 12, 2021NEW APPLICATION ENTERED
Thursday, September 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 28, 2022ASSIGNED TO EXAMINER
Monday, April 11, 2022NON-FINAL ACTION WRITTEN
Monday, April 11, 2022NON-FINAL ACTION E-MAILED
Monday, April 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 15, 2022SUSPENSION LETTER WRITTEN
Tuesday, November 15, 2022LETTER OF SUSPENSION E-MAILED
Tuesday, November 15, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, June 26, 2023SUSPENSION INQUIRY WRITTEN
Monday, June 26, 2023INQUIRY TO SUSPENSION E-MAILED
Monday, June 26, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Saturday, September 16, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 7, 2024ASSIGNED TO LIE
Wednesday, February 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 7, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 14, 2024SUSPENSION LETTER WRITTEN
Wednesday, February 14, 2024LETTER OF SUSPENSION E-MAILED
Wednesday, February 14, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 14, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, February 3, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, February 3, 2025SUSPENSION INQUIRY WRITTEN
Monday, February 3, 2025INQUIRY TO SUSPENSION E-MAILED

Related Keywords

glycosan pharmaceuticals manufacture polymers based chitosan